Bio-Path (NASDAQ:BPTH) Now Covered by Analysts at StockNews.com
StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research note issued to investors on Wednesday. The brokerage issued a sell rating on the stock. Bio-Path Stock Down 10.4% Shares of Bio-Path stock opened at $0.17 on Wednesday. The company has a fifty day moving average of $0.16 and a 200 […]
